secwatch.observer — SEC 8-K summary
======================================

Issuer:     Armata Pharmaceuticals, Inc. (ARMP)
CIK:        0000921114
Form:       8-K
Filed at:   2026-06-16T20:43:32+00:00
Accession:  0001104659-26-074618
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Armata shareholders elect directors, approve advisory votes, ratify auditor at 2026 annual meeting
--------------------------------------------------------------------------------

- All seven director nominees elected for one-year terms: Deborah Birx, Daniel Gilmer, Jules Haimovitz, Odysseas Kostas, Robin Kramer, Joseph Patti, Sarah Schlesinger.
- Non-binding advisory vote on named executive officer compensation approved: 28,547,283 for, 27,765 against, 1,257,467 broker non-votes.
- One-year frequency for future advisory votes on executive compensation selected: 28,567,809 for one year, 2,400 for two years.
- Ratification of Ernst & Young as independent auditor for FY2026 passed: 29,842,514 for, 6,631 against, 0 broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/921114/000110465926074618/0001104659-26-074618-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/921114/000110465926074618/tm2618097d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-074618

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer